Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 7, 2025 • 8:00 AM ET

Date/Time Source News Release
07/01/2025 08:14 AM EDT GlobeNewswire Indaptus Therapeutics, Inc. Announces Additional Sale of $3.4 Million in Private Placement of Convertible Notes and Warrants
06/25/2025 07:00 AM EDT GlobeNewswire Indaptus Therapeutics Announces Reverse Stock Split
06/13/2025 08:00 AM EDT GlobeNewswire Indaptus Therapeutics, Inc. Announces Sale of $2.3 Million in Private Placement of Convertible Notes and Warrants
06/02/2025 08:00 AM EDT GlobeNewswire Indaptus Therapeutics Doses First Patient in Phase 1b/2 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab
05/14/2025 08:00 AM EDT GlobeNewswire Indaptus Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
05/08/2025 08:00 AM EDT GlobeNewswire Indaptus Therapeutics Founder and Chief Scientific Officer Dr. Michael Newman Named Chair and Expert Speaker at 6th Annual Cytokine-Based Drug Development Summit
03/25/2025 08:00 AM EDT GlobeNewswire Indaptus Therapeutics Chief Medical Officer Roger Waltzman, M.D., M.B.A. to Moderate Panel at CMO360 Summit
03/20/2025 08:00 AM EDT GlobeNewswire Indaptus Therapeutics Reports New Data Demonstrating Successful Broad Immune System Activation in Weekly Dosing Trial of Decoy20
03/18/2025 08:00 AM EDT GlobeNewswire Indaptus Therapeutics Initiates Phase 1 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab
03/13/2025 07:30 AM EDT GlobeNewswire Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update
Page

Additional News

As of July 7, 2025 • 8:00 AM ET

Date/Time Source News Release
06/25/2025 07:57 AM EDT SeekingAlpha Indaptus Therapeutics to execute 1-for-28 reverse stock split
06/24/2025 11:10 AM EDT Financial News Media Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices
06/13/2025 08:39 AM EDT SeekingAlpha Indaptus Therapeutics announces sale of $2.3M of convertible notes, warrants
05/14/2025 09:36 AM EDT SeekingAlpha Indaptus Therapeutics GAAP EPS of -$0.32 misses by $0.14
05/14/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Wednesday, May 14th, 2025
05/14/2025 05:30 AM EDT US Earnings Reports Expected earnings - Indaptus Therapeutics Inc.
05/13/2025 06:48 PM EDT KlickAnalytics INDP - Historical Price Movements Surrounding Earnings
05/13/2025 06:43 PM EDT KlickAnalytics INDP - Historical Earnings Price Analysis
03/13/2025 09:34 AM EDT SeekingAlpha Indaptus Therapeutics GAAP EPS of -$1.61
03/12/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Wednesday, March 12th, 2025
Page